Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72046362a91a0f0277abe5495e47790f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056 |
filingDate |
2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0329fdca0ed605032c297e05e043972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926bce8f493d200badea567982ab4fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4473abc90de06da25d3604b491bfe1c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d59ae320e2fc5082eaab2e9b9d69f2 |
publicationDate |
2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015307508-A1 |
titleOfInvention |
Application of an alkaloid derived from a Chinese herbal for treatment of cancer by inhibiting cholesterol synthesis and fatty acid oxidation |
abstract |
The present invention discloses a method of treating Gefitinib-resistant non-small-cell lung cancer, comprising administering an effective amount of an alkaloid. A pharmaceutical composition comprising an alkaloid admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer is also disclosed therein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109125327-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105434435-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105434435-B |
priorityDate |
2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |